Effects of a new oral hypoglycemic agent on glucose and insulin after oral glucose loading. A controlled study.
D000284:Administration, Oral; D000328:Adult; D001786:Blood Glucose / Q000032:analysis*; D001830:Body Surface Area; D002986:Clinical Trials as Topic; D005215:Fasting; D005947:Glucose / Q000008:administration & dosage; D005951:Glucose Tolerance Test; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007097:Imines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D007328:Insulin / Q000097:blood*; D008297:Male; D009325:Nausea / Q000139:chemically induced; D010629:Phenformin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D010919:Placebos; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D011743:Pyrimidines / Q000008:administration & dosage / Q000494:pharmacology; D013997:Time Factors
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007097:Imines; D007328:Insulin; D010919:Placebos; D011725:Pyridines; D011743:Pyrimidines; D010629:Phenformin; D005947:Glucose